Production of recombinant human long-acting IL-18 binding protein: inhibitory effect on ulcerative colitis in mice.

MLA

Guo, Lei, et al. “Production of Recombinant Human Long-Acting IL-18 Binding Protein: Inhibitory Effect on Ulcerative Colitis in Mice.” Applied Microbiology and Biotechnology, vol. 107, no. 23, Dec. 2023, pp. 7135–50. EBSCOhost, https://doi.org/10.1007/s00253-023-12806-8.

APA

Guo, L., Chen, X., Zeng, H., Tian, N., Lu, W., Zhang, J., & Xiao, Y. (2023). Production of recombinant human long-acting IL-18 binding protein: inhibitory effect on ulcerative colitis in mice. Applied Microbiology and Biotechnology, 107(23), 7135–7150. https://doi.org/10.1007/s00253-023-12806-8

Chicago

Guo, Lei, Xiuze Chen, Haifeng Zeng, Na Tian, Weijie Lu, Jizhou Zhang, and Yechen Xiao. 2023. “Production of Recombinant Human Long-Acting IL-18 Binding Protein: Inhibitory Effect on Ulcerative Colitis in Mice.” Applied Microbiology and Biotechnology 107 (23): 7135–50. doi:10.1007/s00253-023-12806-8.